» Authors » Ali Osmanov

Ali Osmanov

Explore the profile of Ali Osmanov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 28
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huseynov R, Javadov S, Osmanov A, Khasiyev S, Valiyeva S, Almammadova E, et al.
Ther Adv Infect Dis . 2021 Sep; 8:20499361211043969. PMID: 34497715
Background: Azerbaijan is an upper middle-income country in South Caucasus with an area of 86,600 km and a total population of 10 million people and gross domestic product of US ...
2.
Osmanov A, Farooq Z, Richardson M, Denning D
FEMS Microbiol Rev . 2020 May; 44(4):399-417. PMID: 32386213
Miramistin is a topical antiseptic with broad antimicrobial action, including activity against biofilms and a clinical profile showing good tolerability. Miramistin was developed within a framework of the Soviet Union...
3.
Turdumambetova G, Osmanov A, Denning D
J Fungi (Basel) . 2019 Jul; 5(3). PMID: 31331088
Kyrgyzstan in Central Asia has a population of 6 million people who have high mortality rates for chronic lung diseases. The mountainous geography, widespread use of biomass fuels for cooking...
4.
Bobokhojaev O, Osmanov A, Aliev S, Radjabzoda A, Avgonov Z, Manonov S, et al.
J Fungi (Basel) . 2019 Jul; 5(3). PMID: 31330914
Tajikistan is a low-income country in Middle Asia with a population of 8.9 million people. Five percent of the population lives on less than 1.9 USD a day and 54%...
5.
Osmanov A, Wise A, Denning D
J Med Microbiol . 2019 Jun; 68(7):1047-1052. PMID: 31169488
Introduction: Miramistin is a topical antiseptic with broad antimicrobial activity that was developed in the Soviet Union during the Cold War. Aim: To investigate the antifungal activity of miramistin against...
6.
Osmanov A, Denning D
Mycoses . 2015 Oct; 58 Suppl 5:94-100. PMID: 26449513
Ukraine has high rates of TB, AIDS and cancer. We estimated the burden of fungal disease from epidemiology papers and specific populations at risk and fungal infection frequencies. HIV/AIDS cases...
7.